Plain-English translation of NCT07515014 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help people with lupus—a serious autoimmune disease where the body attacks its own tissues—feel better and have fewer symptoms. Researchers want to find the right dose of this medication and compare it to a placebo (a dummy pill) to see if it truly works. About 256 people will participate over 24 weeks.
Many people with lupus still struggle with their symptoms even while taking standard treatments like steroids and other medications. This study aims to find out if this new treatment can help reduce lupus activity more effectively and allow patients to potentially lower their steroid doses.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the new medication (at one of three different doses) or a placebo by mouth, while continuing your current lupus medications at low doses. You'll visit the clinic regularly over 24 weeks so doctors can monitor how well the treatment is working and check for any side effects. Blood tests and assessments of your lupus symptoms will help the research team measure whether the medication is helping you.
AI-generated summary from trial data · Aug 28, 2026 · Not medical advice
China